Medical device maker Abbott Laboratories maintained its annual profit forecast on Wednesday and said it expected the U.S.

Abbott Laboratories will make new investments in US manufacturing, with the impact of tariffs on medical devices and ...

The Illinois expansion will happen at the company’s headquarters campus in Abbott Park. It's also growing in Dallas.

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

Abbott's growth potential with GLP-1 tailwinds, robust FCF, and dividend growth. Read more on how ABT navigates tariffs while ...

Abbott expects to spend $500 million on two facilities, located in Illinois and Texas, the company said in a statement.

Abbott's diversified global supply chain and 25 new products in the pipeline position it well to navigate tariff impacts and ...

Abbott Laboratories has today maintained its annual profit forecast and announced $500m in manufacturing and research ...

Products made in China and sold in the US ... Speaking on China's enormous impact in the pharmaceutical and healthcare sectors, Rizzuto said that the vast majority of healthcare companies use ...

and the stock surges to lead the S&P 500 index's gainers Abbott Laboratories saw a big jump in demand for its diabetes products in the first quarter, which helped the medical-device company extend ...

Ghamrawy emphasized the importance of adhering to the proposed timeline to ensure the timely start of local production. He ...